ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Cancer
Breast Cancer
Carcinoma
Non-Small-Cell Lung Carcinoma
Triple Negative Breast Cancer
Colorectal Cancer

Endometrial Cancer trials near Salt Lake City, UT, USA:

Abemaciclib and Letrozole to Treat Endometrial Cancer

letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...

Active, not recruiting
Endometrial Cancer
Drug: Letrozole
Drug: Abemaciclib

Phase 2

Gynecologic Oncology Group (GOG)

Salt Lake City, Utah, United States and 28 other locations

to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...

Enrolling
Endometrial Adenocarcinoma
Drug: ACR-368
Drug: Gemcitabine

Phase 2

Acrivon Therapeutics

Salt Lake City, Utah, United States and 68 other locations

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...

Enrolling
Uterine Cancer
Hormone Receptor-positive/Her2 Negative Breast Cancer
Drug: Carboplatin
Drug: Pembrolizumab

Phase 1, Phase 2

Genmab
Genmab

West Valley City, Utah, United States of America and 37 other locations

The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.

Enrolling
Endometrial Cancer
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Drug: Pembrolizumab
Drug: IDE-161

Phase 1

Ideaya Biosciences

West Valley City, Utah, United States of America and 26 other locations

The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor...

Enrolling
Solid Tumor
Ovarian Neoplasms
Drug: NKT3964

Phase 1

NiKang Therapeutics

Salt Lake City, Utah, United States and 7 other locations

The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors...

Enrolling
Uterine Cervical Neoplasms
Ovarian Neoplasms
Drug: carboplatin
Drug: LY4170156

Phase 1

Lilly
Lilly

West Valley City, Utah, United States of America and 24 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1

Exelixis
Exelixis

Salt Lake City, Utah, United States and 123 other locations

Locations recently updated

A Study of XMT-1660 in Solid Tumors...

Enrolling
Endometrial Cancer
Breast Cancer
Drug: XMT-1660

Phase 1

Mersana Therapeutics

Salt Lake City, Utah, United States and 22 other locations

Status recently updated

The purpose of this study is to measure the safety and efficacy of LY4175408 in participants with selected advanced cancer. In addition, thi...

Not yet enrolling
Enrolling
Neoplasm Metastasis
Triple Negative Breast Cancer
Drug: LY4175408

Phase 1

Lilly
Lilly

West Valley City, Utah, United States of America and 23 other locations

This is a Phase 1/2, open-label, first-in-human (FIH) study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (P...

Active, not recruiting
Endometrial Cancer
HR+ Breast Cancer
Drug: Ribociclib
Drug: Fulvestrant

Phase 1, Phase 2

Blueprint Medicines

Salt Lake City, Utah, United States and 22 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems